5-Aminosalicylic Acid Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

5-Aminosalicylic Acid Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Report Code: KNJ554142 | No. of Pages: 161 | Category: Chemicals and Materials
Publisher: 99Strategy | Date of Publish: Nov-2020
Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global 5-Aminosalicylic Acid market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global 5-Aminosalicylic Acid market segmented into
    High Purity
    Low Purity

Based on the end-use, the global 5-Aminosalicylic Acid market classified into
    Enteric-coated Tablets Product
    Capsule Product
    Others

Based on geography, the global 5-Aminosalicylic Acid market segmented into
    North America [U.S., Canada, Mexico]
    Europe [Germany, UK, France, Italy, Rest of Europe]
    Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
    South America [Brazil, Argentina, Rest of Latin America]
    Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
    Taj Pharmaceuticals Ltd
    Cambrex
    Sunflower
    Hubei Ocean Biotech Co., Ltd
    Lasa Loboratory
    ALP PHARM BEIJING CO LTD, CHINA
    BAYER PHARMA AG, GERMANY
    CADILA HEALTHCARE LTD, INDIA
    CHEMI SPA, ITALY
    CILAG CHEMIE AG, SWITZERLAND
    CORDEN PHARMA BERGAMO SPA, ITALY
    CTX LIFE SCIENCES PVT LTD, INDIA
    DEAFARMA, Italy
    DIVIS LABORATORIES LTD, INDIA
    DK Pharmachem Pvt. Ltd, India
    DR REDDYS LABORATORIES LTD, INDIA
    EASTMAN CHEMICAL CO, UNITED STATES
    ERREGIERRE SPA, ITALY
    INFAR SA, SPAIN
    IPCA LABORATORIES LTD, INDIA
    LUPIN LTD, INDIA
    PharmaZell (Vizag) Private Limited, JAPAN
    PHARMAZELL GMBH, GERMANY
    PLIVA CROATIA LTD, Croatia
    SIGMA F AND D DIV LTD, UNITED STATES
    SIMS SRL, ITALY
    SUN PHARMACEUTICAL INDUSTRIES LTD, INDIA
    SYNTESE AS, DENMARK
    TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL
    WAITAKI INTERNATIONAL
Table of Contents
1  RESEARCH SCOPE
    1.1 Research Product Definition
    1.2 Research Segmentation
        1.2.1 Product Type
        1.2.2 Main product Type of Major Players
    1.3 Demand Overview
    1.4 Research Methodology
2 GLOBAL 5-AMINOSALICYLIC ACID INDUSTRY
    2.1 Summary about 5-Aminosalicylic Acid Industry
    2.2 5-Aminosalicylic Acid Market Trends
        2.2.1 5-Aminosalicylic Acid Production & Consumption Trends
        2.2.2 5-Aminosalicylic Acid Demand Structure Trends
    2.3 5-Aminosalicylic Acid Cost & Price
3  MARKET DYNAMICS
    3.1 Manufacturing & Purchasing Behavior in 2020
    3.2 Market Development under the Impact of COVID-19
        3.2.1 Drivers
        3.2.2 Restraints
        3.2.3 Opportunity
        3.2.4 Risk
4  GLOBAL MARKET SEGMENTATION
    4.1 Region Segmentation (2017 to 2021f)
        4.1.1 North America (U.S., Canada and Mexico)
        4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
        4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
        4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
        4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
    4.2 Product Type Segmentation (2017 to 2021f)
        4.2.1 High Purity
        4.2.2 Low Purity
    4.3 Consumption Segmentation (2017 to 2021f)
        4.3.1 Enteric-coated Tablets Product
        4.3.2 Capsule Product
        4.3.3 Others
5  NORTH AMERICA MARKET SEGMENT
    5.1 Region Segmentation (2017 to 2021f)
        5.1.1 U.S.
        5.1.2 Canada
        5.1.3 Mexico
    5.2 Product Type Segmentation (2017 to 2021f)
        5.2.1 High Purity
        5.2.2 Low Purity
    5.3 Consumption Segmentation (2017 to 2021f)
        5.3.1 Enteric-coated Tablets Product
        5.3.2 Capsule Product
        5.3.3 Others
    5.4 Impact of COVID-19 in North America
6  EUROPE MARKET SEGMENTATION
    6.1 Region Segmentation (2017 to 2021f)
        6.1.1 Germany
        6.1.2 UK
        6.1.3 France
        6.1.4 Italy
        6.1.5 Rest of Europe
    6.2 Product Type Segmentation (2017 to 2021f)
        6.2.1 High Purity
        6.2.2 Low Purity
    6.3 Consumption Segmentation (2017 to 2021f)
        6.3.1 Enteric-coated Tablets Product
        6.3.2 Capsule Product
        6.3.3 Others
    6.4  Impact of COVID-19 in Europe
7  ASIA-PACIFIC MARKET SEGMENTATION
    7.1 Region Segmentation (2017 to 2021f)
        7.1.1 China
        7.1.2 India
        7.1.3 Japan
        7.1.4 South Korea
        7.1.5 Southeast Asia
        7.1.6 Australia
        7.1.7 Rest of Asia Pacific
    7.2 Product Type Segmentation (2017 to 2021f)
        7.2.1 High Purity
        7.2.2 Low Purity
    7.3 Consumption Segmentation (2017 to 2021f)
        7.3.1 Enteric-coated Tablets Product
        7.3.2 Capsule Product
        7.3.3 Others
    7.4  Impact of COVID-19 in Europe
8  SOUTH AMERICA MARKET SEGMENTATION
    8.1 Region Segmentation (2017 to 2021f)
        8.1.1 Brazil
        8.1.2 Argentina
        8.1.3 Rest of Latin America
    8.2 Product Type Segmentation (2017 to 2021f)
        8.2.1 High Purity
        8.2.2 Low Purity
    8.3 Consumption Segmentation (2017 to 2021f)
        8.3.1 Enteric-coated Tablets Product
        8.3.2 Capsule Product
        8.3.3 Others
    8.4  Impact of COVID-19 in Europe
9  MIDDLE EAST AND AFRICA MARKET SEGMENTATION
    9.1 Region Segmentation (2017 to 2021f)
        9.1.1 GCC
        9.1.2 North Africa
        9.1.3 South Africa
        9.1.4 Rest of Middle East and Africa
    9.2 Product Type Segmentation (2017 to 2021f)
        9.2.1 High Purity
        9.2.2 Low Purity
    9.3 Consumption Segmentation (2017 to 2021f)
        9.3.1 Enteric-coated Tablets Product
        9.3.2 Capsule Product
        9.3.3 Others
    9.4  Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
    10.1 Brief Introduction of Major Players
        10.1.1 Taj Pharmaceuticals Ltd
        10.1.2 Cambrex
        10.1.3 Sunflower
        10.1.4 Hubei Ocean Biotech Co., Ltd
        10.1.5 Lasa Loboratory
        10.1.6 ALP PHARM BEIJING CO LTD, CHINA
        10.1.7 BAYER PHARMA AG, GERMANY
        10.1.8 CADILA HEALTHCARE LTD, INDIA
        10.1.9 CHEMI SPA, ITALY
        10.1.10 CILAG CHEMIE AG, SWITZERLAND
        10.1.11 CORDEN PHARMA BERGAMO SPA, ITALY
        10.1.12 CTX LIFE SCIENCES PVT LTD, INDIA
        10.1.13 DEAFARMA, Italy
        10.1.14 DIVIS LABORATORIES LTD, INDIA
        10.1.15 DK Pharmachem Pvt. Ltd, India
        10.1.16 DR REDDYS LABORATORIES LTD, INDIA
        10.1.17 EASTMAN CHEMICAL CO, UNITED STATES
        10.1.18 ERREGIERRE SPA, ITALY
        10.1.19 INFAR SA, SPAIN
        10.1.20 IPCA LABORATORIES LTD, INDIA
        10.1.21 LUPIN LTD, INDIA
        10.1.22 PharmaZell (Vizag) Private Limited, JAPAN
        10.1.23 PHARMAZELL GMBH, GERMANY
        10.1.24 PLIVA CROATIA LTD, Croatia
        10.1.25 SIGMA F AND D DIV LTD, UNITED STATES
        10.1.26 SIMS SRL, ITALY
        10.1.27 SUN PHARMACEUTICAL INDUSTRIES LTD, INDIA
        10.1.28 SYNTESE AS, DENMARK
        10.1.29 TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL
        10.1.30 WAITAKI INTERNATIONAL
    10.2  5-Aminosalicylic Acid Sales Date of Major Players (2017-2020e)
        10.2.1 Taj Pharmaceuticals Ltd
        10.2.2 Cambrex
        10.2.3 Sunflower
        10.2.4 Hubei Ocean Biotech Co., Ltd
        10.2.5 Lasa Loboratory
        10.2.6 ALP PHARM BEIJING CO LTD, CHINA
        10.2.7 BAYER PHARMA AG, GERMANY
        10.2.8 CADILA HEALTHCARE LTD, INDIA
        10.2.9 CHEMI SPA, ITALY
        10.2.10 CILAG CHEMIE AG, SWITZERLAND
        10.2.11 CORDEN PHARMA BERGAMO SPA, ITALY
        10.2.12 CTX LIFE SCIENCES PVT LTD, INDIA
        10.2.13 DEAFARMA, Italy
        10.2.14 DIVIS LABORATORIES LTD, INDIA
        10.2.15 DK Pharmachem Pvt. Ltd, India
        10.2.16 DR REDDYS LABORATORIES LTD, INDIA
        10.2.17 EASTMAN CHEMICAL CO, UNITED STATES
        10.2.18 ERREGIERRE SPA, ITALY
        10.2.19 INFAR SA, SPAIN
        10.2.20 IPCA LABORATORIES LTD, INDIA
        10.2.21 LUPIN LTD, INDIA
        10.2.22 PharmaZell (Vizag) Private Limited, JAPAN
        10.2.23 PHARMAZELL GMBH, GERMANY
        10.2.24 PLIVA CROATIA LTD, Croatia
        10.2.25 SIGMA F AND D DIV LTD, UNITED STATES
        10.2.26 SIMS SRL, ITALY
        10.2.27 SUN PHARMACEUTICAL INDUSTRIES LTD, INDIA
        10.2.28 SYNTESE AS, DENMARK
        10.2.29 TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL
        10.2.30 WAITAKI INTERNATIONAL
    10.3  Market Distribution of Major Players
    10.4 Global Competition Segmentation
11  MARKET FORECAST
    11.1  Forecast by Region
    11.2  Forecast by Demand
    11.3  Environment Forecast
        11.3.1  Impact of COVID-19
        11.3.2  Geopolitics Overview
        11.3.3  Economic Overview of Major Countries
12  REPORT SUMMARY STATEMENT

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com